Cigna Corp (CI)

Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers.

This top health insurer scans as a downright bargain at current levels.

Speculation over a potential Berkshire Hathaway stake, alongside big moves from notable institutional investors, has added to the momentum in UnitedHealth shares.

A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.

Health insurance company Cigna (NYSE:CI) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per share was 0.6% above analysts’ consensus estimates.

Cigna’s second quarter results were met with a significant negative market reaction, reflecting investor concerns despite revenue and adjusted earnings per share both coming in ahead of Wall Street expectations. Management attributed the quarter’s results to continued momentum in its Evernorth services platform and the resilience of its U.S. employer business. However, persistent elevated medical costs, especially in the commercial and individual exchange segments, remained a notable challenge. CEO David Cordani described the company’s performance as “differentiated,” but acknowledged industry disruption and the necessity of ongoing portfolio adjustments. Management also highlighted product innovation, such as new GLP-1 benefit options and AI-powered virtual assistance, as key contributors to maintaining customer engagement and operational execution.

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.

According to a Bloomberg News report, Trump already met JPMorgan Chase & Co. CEO Jamie Dimon last week at the White House, followed by talks with Goldman Sachs CEO David Solomon on Thursday.

Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights.

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.

Health insurance company Cigna (NYSE:CI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 11.1% year on year to $67.18 billion. Its non-GAAP profit of $7.20 per share was 0.6% above analysts’ consensus estimates.

Cigna Group (NYSE:CI) beat Q2 revenue estimates but slightly missed on EPS, reaffirming full-year guidance. Shares rose 4.4% pre-market as investors focused on growth.

Health insurance company Cigna (NYSE:CI) will be reporting earnings this Thursday before the bell. Here’s what investors should know.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".